drugset / Trial / NCT03019614

An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone

NCT03019614

Phase 1 Completed 30 enrolled Neurocrine UK Limited Simbec Research · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This was an open label, randomized, single dose, three period crossover pharmacokinetic study of Chronocort® in 30 healthy male volunteers. The study was conducted in smaller sub groups (Group 1, n=18 and Group 2, n=12).

Timeline

Start
2010-03
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Chronocort Unknown 5 mg Oral
Subject Chronocort Unknown 10 mg Oral
Subject Chronocort Unknown 20 mg Oral
Subject Chronocort Unknown 30 mg Oral
Subject Hydrocortisone Other / unclassified 30 mg Oral